Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Puretech Health Plc ADR
(NQ:
PRTC
)
19.50
+0.07 (+0.36%)
Streaming Delayed Price
Updated: 3:53 PM EDT, Sep 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Puretech Health Plc ADR
< Previous
1
2
3
4
5
6
7
Next >
PureTech to Present at 40th Annual J.P. Morgan Healthcare Conference
January 07, 2022
From
PureTech Health plc
Via
Business Wire
PureTech’s LYT-100 (Deupirfenidone) Achieves 50% Reduction in Healthy Older Adults Experiencing GI-Related Adverse Events Compared to Pirfenidone
January 06, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Gelesis Appoints Inogen Co-Founder and Former CFO Ali Bauerlein to Board of Directors and Audit Committee
January 05, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Provides End of Year Report on Key Progress Across Wholly Owned Programs and Founded Entities
December 16, 2021
From
PureTech Health
Via
Business Wire
PureTech Presents Preclinical Proof-of-Concept Data for LYT-300 (Oral Allopregnanolone) as Potential Treatment for Neurological and Neuropsychological Conditions
December 08, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Advances Wholly-Owned Candidate LYT-300 (Oral Allopregnanolone) into Clinical Study for Potential Treatment of Neurological and Neuropsychological Conditions
December 07, 2021
From
PureTech Health plc
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
December 02, 2021
Gainers Biofrontera (NASDAQ:BFRI) shares ...
Via
Benzinga
PureTech Founded Entity Gelesis Announces FDA-Cleared Weight Management Approach, Plenity®, Now Broadly Available and Leading Nutrition Authority Joy Bauer, MS, RDN, CDN, Joins as Chief Nutrition Officer
December 01, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Gelesis Receives $30 Million Plenity® Order from Ro
November 18, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Announces Publication of Phase 1 Results for LYT-100 in the Journal Clinical Pharmacology in Drug Development and Provides Timing Updates
November 16, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Announces Participation in Two Upcoming Investor Conferences
November 15, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Presents Clinical Trial Design Supporting Wholly Owned Immuno-Oncology Candidate LYT-200 at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
November 12, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Receives Orphan Drug Designation for Wholly Owned Candidate LYT-200 for the Treatment of Pancreatic Cancer
November 11, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Karuna Therapeutics and Zai Lab Announce Strategic Collaboration for Development, Manufacturing, and Commercialization of KarXT in Greater China
November 09, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Announces Participation at the Jefferies London Healthcare Conference
November 09, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Is Pleased to Note Publication in Nature’s Scientific Reports Featuring the Gelesis Foundational Biomimetic Platform for Treating Obesity and Conditions Related to Diet-Induced Gut Damage
November 01, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Vedanta Biosciences Appoints Simona Levi as Chief Legal Officer and Corporate Secretary
October 14, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Vedanta Announces Positive Topline Phase 2 Data for VE303 in High-Risk C. difficile Infection and Exercise of $23.8 Million Option by BARDA
October 05, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Sonde Health Launches Vocal Biomarker Technology to Monitor Mental Health and Well-Being
October 05, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Akili Announces Topline Results from Shionogi Phase 2 Study in Japan
September 29, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Announces Publication of New Preclinical Research from Collaborators that Supports Mesenteric Lymphatic Dysfunction as a Potential Cause of and Therapeutic Target for Obesity and Insulin Resistance
September 20, 2021
From
PureTech Health plc
Via
Business Wire
PureTech to Present at Oppenheimer Fall Healthcare Life Sciences and MedTech Summit
September 14, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Vor Biopharma Announces VOR33 Granted U.S. FDA Fast Track Designation for Acute Myeloid Leukemia
September 10, 2021
From
PureTech Health plc
Via
Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
August 30, 2021
Gainers Valneva (NASDAQ:VALN) stock moved upwards by 29.61% to $49.9 during Monday's regular session. Valneva's stock is trading at a volume of 143.0K shares as of...
Via
Benzinga
Earnings Scheduled For August 24, 2021
August 24, 2021
Companies Reporting Before The Bell • 36KR Holdings (NASDAQ:KRKR) is likely to report earnings for its second quarter. • Genetron Holdings (NASDAQ:GTH) is...
Via
Benzinga
PureTech Health plc – Half-Year Report
August 24, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Presents Phase 1 Data for LYT-100 at the European Respiratory Society International Congress 2021
August 23, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Akili Enters Strategic Licensing Agreement with TALi, Extending Akili Portfolio and Industry Leadership in Prescription Digital Therapeutics for Cognitive Impairments
August 17, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Announces the Appointment Julie Krop, M.D., as Chief Medical Officer
August 13, 2021
From
PureTech Health plc
Via
Business Wire
Imbrium Therapeutics To Develop PureTech's Non-Opioid Candidate For Chronic Bladder Condition
August 11, 2021
Imbrium Therapeutics has exercised a license option to develop PureTech Health plc's (NASDAQ: PRTC) LYT-503/IMB-150 (formerly designated as ALV-107...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.